Company: CGC
Filing Date: 2025-05-29
Form Type: POSASR
Source: 0001104659-25-054285
Chunk: 37

Company: Canopy Growth Corp
Filing Date: 2025-05-29
Form: POSASR
Chunk 37
---
 $200,000,000 from time to time through the Agent, including any amounts sold in Canada through the Canadian Agent pursuant to the Canadian Prospectus (the “Concurrent Canadian Offering”). As of May 29, 2025, we have sold $27,930,365 of Common Shares under the Equity Distribution Agreement. Accordingly, under this prospectus supplement and the accompanying prospectus, we may offer and sell the remaining Common Shares under the Equity Distribution Agreement having an aggregate offering price of up to $172,069,635. The maximum offering size of this offering, including any sales under the Concurrent Canadian Offering after the date hereof, will not exceed $172,069,635.

Our Common Shares are listed and posted for trading on the Toronto Stock Exchange (the “TSX”) under the symbol “WEED” and the Nasdaq Global Select Market under the symbol “CGC.” On May 28, 2025, the closing price of our Common Shares on the Nasdaq Global Select Market was $1.77 per share.

Sales of our Common Shares, if any, under this prospectus supplement and the accompanying prospectus will be made in sales deemed to be “at the market offerings” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”). The Agent will only sell Common Shares in the United States, and the Canadian Agent will only sell Common Shares on marketplaces in Canada. The Agent is not required to sell any specific number or dollar amount of securities, but will act as our sales agent using commercially reasonable efforts to sell on our behalf all of the Common Shares requested to be sold by us, consistent with its normal trading and sales practices, on mutually agreed terms between the Agent and us.

We will pay the Agent compensation equal to up to 3% of the gross sales price of Common Shares sold by the Agent under the Equity Distribution Agreement (the “Commission”). In connection with the sale of Common Shares on our behalf, the Agent will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the Agent will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to the Agent with respect to certain liabilities, including liabilities under the Securities Act.

Investing in our Common Shares involves risks. See “Risk Factors” on page S-5of this prospectus supplement, as well as our other filings that are incorporated by reference